7F09
Crystal structure of the HLH-Lz domain of human TFE3
7F09 の概要
| エントリーDOI | 10.2210/pdb7f09/pdb |
| 分子名称 | Transcription factor E3, 1,2-ETHANEDIOL, ZINC ION, ... (4 entities in total) |
| 機能のキーワード | transcription factor e3, hlh-lz domain, transcription |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 35268.12 |
| 構造登録者 | |
| 主引用文献 | Yang, G.,Li, P.,Liu, Z.,Wu, S.,Zhuang, C.,Qiao, H.,Zheng, L.,Fang, P.,Lei, C.,Wang, J. Structural basis for the dimerization mechanism of human transcription factor E3. Biochem.Biophys.Res.Commun., 569:41-46, 2021 Cited by PubMed Abstract: The transcription factor for immunoglobulin heavy-chain enhancer 3 (TFE3) is a member of the microphthalmia (MiT/TFE) transcription factor family. Dysregulation of TFE3 due to chromosomal abnormalities is associated with a subset of human renal cell carcinoma. Little structural information of this key transcription factor has been reported. In this study, we determined the crystal structure of the helix-loop-helix leucine zipper (HLH-Lz) domain of human TFE3 to a resolution of 2.6 Å. The HLH-Lz domain is critical for the dimerization and function of TFE3. Our structure showed that the conserved HLH region formed a four-helix bundle structure with a predominantly hydrophobic core, and the leucine zipper region contributed to the function of TFE3 by promoting dimer interaction and providing partner selectivity. Together, our results elucidated the dimerization mechanism of this important transcription factor, providing the structural basis for the development of inhibiting strategies for treating TFE3 dysregulated diseases. PubMed: 34225079DOI: 10.1016/j.bbrc.2021.06.091 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






